| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.0M | -22.7% | -77.6% |
| SG&A Expense | $7.9M | -80.4% | -38.9% |
| Operating Income | -$11.9M | +73.9% | +61.3% |
| Income Tax | $0 | — | — |
| Net Income | -$10.8M | +75.6% | +61.3% |
| EPS (Basic) | -$0.22 | +76.1% | +62.1% |
| EPS (Diluted) | -$0.22 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $106.1M | -5.6% | -28.8% |
| Current Assets | $108.9M | -5.1% | -46.2% |
| Total Assets | $129.7M | -4.2% | -42.0% |
| Current Liabilities | $48.0M | +1.5% | -15.8% |
| Total Liabilities | $48.2M | +1.6% | -15.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.5M | — | — |
| Capital Expenditures | $80K | — | — |
| Investing Cash Flow | -$80K | — | — |
| Financing Cash Flow | $90K | — | — |
| Free Cash Flow | -$22.6M | — | — |
| +62.1% |
| $81.6M |
| -7.3% |
| -51.1% |